Back to search results

An Observational Study to Assess Real-World Use of Upadacitinib Tablets in Adolescent and Adult Participants With Moderate to Severe Atopic Dermatitis in China

Abroad (travel likely)Recruiting

Conditions

Atopic Dermatitis

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Beijing Anzhen Hospital /ID# 273443, Beijing, Beijing Municipality, China

  • China-Japan Friendship Hospital /ID# 274778, Beijing, Beijing Municipality, China

  • Peking University First Hospital /ID# 274865, Beijing, Beijing Municipality, China

  • Peking Unversity Third hospital /ID# 274864, Beijing, Beijing Municipality, China

  • Peking Union Medical College Hospital (East) - Dongdan Campus /ID# 264193, Beijing, Beijing Municipality, China

  • The First Affiliated Hospital Of Fujian Medical University /ID# 268210, Fuzhou, Fujian, China

  • Changgeng Hospital /ID# 268209, Xiamen, Fujian, China

  • Guangzhou Dermatology Hospital /ID# 271684, Guangzhou, Guangdong, China

  • The Fifth Affiliated Hospital Of Sun Yat-Sen University /ID# 268618, Zhuhai, Guangdong, China

  • Hainan Fifth People's Hospital /ID# 269747, Hainan, Hainan, China

  • Hebei Engineering University Affiliated Hospital /ID# 268660, Handan, Hebei, China

  • The Second Affiliated Hospital Of Harbin Medical University /ID# 270872, Harbin, Heilongjiang, China

  • People's Hospital of Henan Province /ID# 269744, Zhengzhou, Henan, China

  • Wuhan Integrated TCM & Western Medicine Hospital（Wuhan No.1 Hospital) /ID# 272374, Wuhan, Hubei, China

  • Tongji Hospital /ID# 269745, Wuhan, Hubei, China

  • Xiangya Hospital Central South University /ID# 272373, Changsha, Hunan, China

  • Nanjing Drum Tower Hospital /ID# 268616, Nanjing, Jiangsu, China

  • Affiliated Hospital Of Nantong University /ID# 269743, Nantong, Jiangsu, China

  • The First Affiliated Hospital of Soochow University /ID# 269742, Suzhou, Jiangsu, China

  • The Affiliated Hospital of Xuzhou Medical College /ID# 268208, Xuzhou, Jiangsu, China

  • Dalian Dermatosis Hospital /ID# 272495, Dalian, Liaoning, China

  • The People's Hospital of Liaoning Province /ID# 268206, Shenyang, Liaoning, China

  • Shandong Provincial Hospital /ID# 268661, Jinan, Shandong, China

  • Jining Medical University - Affiliated Hospital /ID# 270873, Jining, Shandong, China

  • Weifang People'S Hospital /ID# 268659, Weifang, Shandong, China

  • Ruijin Hospital /ID# 268658, Shanghai, Shanghai Municipality, China

  • Huashan Hospital Of Fudan University /ID# 270277, Shanghai, Shanghai Municipality, China

  • Shanghai Sixth People'S Hospital /ID# 268617, Shanghai, Shanghai Municipality, China

  • Shanghai Skin Disease Hospital /ID# 268657, Shanghai, Shanghai Municipality, China

  • West China Hospital of Sichuan University /ID# 268313, Chengdu, Sichuan, China

  • Sichuan Provincial People's Hospital /ID# 268314, Chengdu, Sichuan, China

  • The Affiliated Hospital Of Southwest Medical University /ID# 268207, Luzhou, Sichuan, China

  • People's Hospital of Xinjiang Uygur Autonomous Region /ID# 269746, Ürümqi, Xinjiang, China

  • The First Affiliated Hospital of Kunming Medical College /ID# 273451, Kunming, Yunnan, China

  • Zhejiang Provincial Hospital of Chinese Medicine /ID# 268613, Hangzhou, Zhejiang, China

  • Ningbo No.6 hospital /ID# 268315, Ningbo, Zhejiang, China

  • Taizhou Central Hospital /ID# 268211, Taizhou, Zhejiang, China

  • Zhuji People'S Hospital /ID# 268614, Zhuji, Zhejiang, China

Study leads

  • ABBVIE INC.

    Study Director

    AbbVie

View source on ClinicalTrials.gov(opens in a new tab)